Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Selchen

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 23, 2013
Treatment optimization in MS: Canadian MS Working Group updated recommendationsMark S Freedman, Daniel Selchen, Douglas L Arnold, et al.
Stroke|June 29, 2017
In-Patient Code Stroke: A Quality Improvement Strategy to Overcome Knowledge-to-Action Gaps in Response TimeCharles D Kassardjian, Jacqueline D Willems, Krystyna Skrabka, et al.
Frontiers in Neurology|October 16, 2018
Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian NeurologistsGustavo Saposnik, Xavier Montalban, Daniel Selchen, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 24, 2012
Fabry's disease: a prospective multicenter cohort study in young adults with cryptogenic strokeGustavo Saposnik, Sylvain Lanthier, Muhammad Mamdani, et al.
Therapeutic Advances in Neurological Disorders|July 9, 2020
Expert opinion on the use of cladribine tablets in clinical practicePer Soelberg Sørensen, Diego Centonze, Gavin Giovannoni, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 24, 2018
Quantitative spinal cord MRI in radiologically isolated syndromePaula Alcaide-Leon, Kateryna Cybulsky, Stephanie Sankar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2021
Cognitive impairment, the central vein sign, and paramagnetic rim lesions in RISJiwon Oh, Suradech Suthiphosuwan, Pascal Sati, et al.
Neurology|December 6, 2012
MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentaryDaniel Selchen, Virender Bhan, Gregg Blevins, et al.
Neurodegenerative Disease Management|October 24, 2022
Expert opinion on COVID-19 vaccines and cladribine tablets in MS: A plain language summaryPeter Rieckmann, Diego Centonze, Gavin Giovannoni, et al.
Therapeutic Advances in Neurological Disorders|December 13, 2021
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practicePeter Rieckmann, Diego Centonze, Gavin Giovannoni, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 23, 2013
Treatment optimization in MS: Canadian MS Working Group updated recommendationsMark S Freedman, Daniel Selchen, Douglas L Arnold, et al.
Stroke|June 29, 2017
In-Patient Code Stroke: A Quality Improvement Strategy to Overcome Knowledge-to-Action Gaps in Response TimeCharles D Kassardjian, Jacqueline D Willems, Krystyna Skrabka, et al.
Frontiers in Neurology|October 16, 2018
Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian NeurologistsGustavo Saposnik, Xavier Montalban, Daniel Selchen, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 24, 2012
Fabry's disease: a prospective multicenter cohort study in young adults with cryptogenic strokeGustavo Saposnik, Sylvain Lanthier, Muhammad Mamdani, et al.
Therapeutic Advances in Neurological Disorders|July 9, 2020
Expert opinion on the use of cladribine tablets in clinical practicePer Soelberg Sørensen, Diego Centonze, Gavin Giovannoni, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 24, 2018
Quantitative spinal cord MRI in radiologically isolated syndromePaula Alcaide-Leon, Kateryna Cybulsky, Stephanie Sankar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2021
Cognitive impairment, the central vein sign, and paramagnetic rim lesions in RISJiwon Oh, Suradech Suthiphosuwan, Pascal Sati, et al.
Neurology|December 6, 2012
MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentaryDaniel Selchen, Virender Bhan, Gregg Blevins, et al.
Neurodegenerative Disease Management|October 24, 2022
Expert opinion on COVID-19 vaccines and cladribine tablets in MS: A plain language summaryPeter Rieckmann, Diego Centonze, Gavin Giovannoni, et al.
Therapeutic Advances in Neurological Disorders|December 13, 2021
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practicePeter Rieckmann, Diego Centonze, Gavin Giovannoni, et al.
Pageof 4